Currently Viewing:
The American Journal of Managed Care September 2015
Do Patient or Provider Characteristics Impact Management of Diabetes?
Erin S. LeBlanc, MD, MPH; A. Gabriela Rosales, MS; Sumesh Kachroo, PhD; Jayanti Mukherjee, PhD; Kristine L. Funk, MS; and Gregory A. Nichols, PhD
The Utility of Cost Discussions Between Patients With Cancer and Oncologists
S. Yousuf Zafar, MD, MHS; Fumiko Chino, MD; Peter A. Ubel, MD; Christel Rushing, MS; Gregory Samsa, PhD; Ivy Altomare, MD; Jonathan Nicolla, MBA; Deborah Schrag, MD; James A. Tulsky, MD; Amy P. Abernethy, MD, PhD; and Jeffery M. Peppercorn, MD, MPH
Building Upon the Strong Foundation of National Healthcare Quality
Charles N. Kahn III, MPH, President and CEO, Federation of American Hospitals
Improving Partnerships Between Health Plans and Medical Groups
Howard Beckman, MD, FACP, FAACH; Patricia Healey, MPH; and Dana Gelb Safran, ScD
Innovative Approach to Patient-Centered Care Coordination in Primary Care Practices
Robin Clarke, MD, MSHS; Nazleen Bharmal, MD, PhD; Paul Di Capua, MD, MBA; Chi-Hong Tseng, PhD; Carol M. Mangione, MD, MSPH; Brian Mittman, PhD; and Samuel A. Skootsky, MD
Private Sector Risk-Sharing Agreements in the United States: Trends, Barriers, and Prospects
Louis P. Garrison, Jr, PhD; Josh J. Carlson, PhD; Preeti S. Bajaj, PhD; Adrian Towse, MA, MPhil; Peter J. Neumann, ScD; Sean D. Sullivan, PhD; Kimberly Westrich, MA; and Robert W. Dubois, MD, PhD
Developing Evidence That Is Fit for Purpose: A Framework for Payer and Research Dialogue
Rajeev K. Sabharwal, MPH; Jennifer S. Graff, PharmD; Erin Holve, PhD, MPH, MPP; and Robert W. Dubois, MD, PhD
Predicting Adherence Trajectory Using Initial Patterns of Medication Filling
Jessica M. Franklin, PhD; Alexis A. Krumme, MS; William H. Shrank, MD, MSHS; Olga S. Matlin, PhD; Troyen A. Brennan, MD, JD, MPH; and Niteesh K. Choudhry, MD, PhD
Currently Reading
Reply to "Transforming Oncology Care": Advancing Value, Accessing Innovation
Rebecca Paradis, MPA
High-Risk Centers and the Benefits for Lower-Risk Transplants
Schelomo Marmor, PhD, MPH; James W. Begun, PhD; Jean Abraham, PhD; and Beth A. Virnig, PhD, MPH
Targeting a High-Risk Group for Fall Prevention: Strategies for Health Plans
Lee A. Jennings, MD, MSHS; David B. Reuben, MD; Sung-Bou Kim, MPhil; Emmett Keeler, PhD; Carol P. Roth, RN, MPH; David S. Zingmond, MD, PhD; Neil S. Wenger, MD, MPH; and David A. Ganz, MD, PhD
Socioeconomic Disparities Across Ethnicities: An Application to Cervical Cancer Screening
Brendan Walsh, PhD; and Ciaran O'Neill, PhD

Reply to "Transforming Oncology Care": Advancing Value, Accessing Innovation

Rebecca Paradis, MPA
Patient access to innovation may be at risk as new payment models emerge in oncology.
ABSTRACT
 
Alternative payment models in oncology are already successfully standardizing care, curbing costs, and improving the patient experience. Yet, it is unclear whether decision makers are adequately considering patient access to innovation when creating these models, which could have severe consequences for a robust innovation ecosystem and the lives of afflicted patients. The suggested chart includes recommendations on: 
  • Allowing for the adoption of new, promising therapies; 
  • Promoting the measurement of patient-centered outcomes; and
  • Providing support for personalized medicine.
 
Am J Manag Care. 2015;21(9):e501-e502
The increasing economic and societal impact of cancer is creating an impetus for change that will likely spread across the health care system in the coming years. As outlined in the May 2015 article from The American Journal of Managed Care, “Transforming Oncology Care: Payment and Delivery Reform for Person-Centered Care,” providers, commercial payers, and the Center for Medicare & Medicaid Innovation are experimenting with a variety of different payment models in oncology, including bundled payments, accountable care organizations, and other financial incentives.

Within the report, the table, “Comparison of Model Approaches,” is useful for tracking the development of cancer payment models. However, based on insights from a recent Network for Excellence in Health Innovation expert roundtable on cancer payment models, we suggest the following additions and recommendations in our Table,1-4 including:
  • Allowing for the adoption of new, promising therapies;
  • Promoting the measurement of patient-centered outcomes; and
  • Providing support for personalized medicine.
Author Affiliation: Network for Excellence in Health Innovation, Cambridge, MA.

Source of Funding: Sponsors for the May 27, 2015 roundtable and corresponding research include Anthem, Blue Cross Blue Shield Association, California HealthCare Foundation, Dana Farber Cancer Institute, and Pfizer.

Author Disclosures: Ms Paradis reports no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.

Authorship Information: Concept and design; analysis and interpretation of data; drafting of the manuscript.

Address correspondence to: Rebecca Paradis, MPA, NEHI, Inc, 1 Broadway, 15th Fl, Cambridge, MA 02142. E-mail: rparadis@nehi.net.
REFERENCES
 
1. Anthem Blue Cross and Blue Shield’s new quality initiative aims to improve cancer outcomes, promote access to evidence-based and cost-effective care [press release]. Mason, OH: Anthem; June 25, 2014. https://www.anthem.com/health-insurance/about-us/pressreleasedetails/OH/2014/1697/anthem-announces-cancer-quality-care-program. Accessed July 10, 2015.

2. WellPoint Cancer Care Quality Program frequently asked questions – California. Anthem Blue Cross Blue Shield website. http://www.anthem.com/ca/provider/f1/s0/t0/pw_e220056.pdf?refer=provider. Updated August 2014. Accessed July 1, 2015.

3. Advancing value in oncology: opportunities and challenges for innovation [video]. Network for Excellence in Health Innovation website. http://www.nehi.net/events/72-advancing-value-in-oncology-opportunities-and-challenges-for-innovation/view. Published June 1, 2015. Accessed July 1, 2015.

4. Horizon Blue Cross Blue Shield of New Jersey announces new collaboration to deliver better care to cancer patients [press release]. Newark, NJ: Blue Cross Blue Shield; September 23, 2014. http://www.bcbs.com/healthcare-news/plans/horizon-bcbsnj-announces-new-collaboration-to-deliver-better-care-to-cancer-patients.html. Accessed July 1, 2015. 
PDF
 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up